SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-075630
Filing Date
2020-06-22
Accepted
2020-06-22 16:07:52
Documents
13
Period of Report
2020-06-22

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2023121d1_6k.htm 6-K 14788
2 EXHIBIT 3.1 tm2023121d1_ex3-1.htm EX-3.1 1332037
3 EXHIBIT 99.1 tm2023121d1_ex99-1.htm EX-99.1 27691
4 GRAPHIC tm2023121d1_ex3-1img01.jpg GRAPHIC 14601
5 GRAPHIC tm2023121d1_ex3-1img02.jpg GRAPHIC 3951
6 GRAPHIC tm2023121d1_ex3-1img03.jpg GRAPHIC 3483
7 GRAPHIC tm2023121d1_ex3-1img04.jpg GRAPHIC 1524
8 GRAPHIC tm2023121d1_ex3-1img05.jpg GRAPHIC 6041
9 GRAPHIC tm2023121d1_ex3-1img06.jpg GRAPHIC 1952
10 GRAPHIC tm2023121d1_ex3-1img07.jpg GRAPHIC 2817
11 GRAPHIC tm2023121d1_ex3-1img08.jpg GRAPHIC 2239
12 GRAPHIC tm2023121d1_ex3-1img09.jpg GRAPHIC 2136
13 GRAPHIC tm2023121d1_ex99-1img001.jpg GRAPHIC 7315
  Complete submission text file 0001104659-20-075630.txt   1440623
Mailing Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000
Business Address SMEDELAND 36 2600 GLOSTRUP COPENHAGEN G7 00000 4588773600
Zealand Pharma A/S (Filer) CIK: 0001674988 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38178 | Film No.: 20978887
SIC: 2834 Pharmaceutical Preparations